The Tale of IL-12 and IL-23: A Paradigm Shift

Interleukin-12 was considered to be the driving force behind pathological conditions associated with several autoimmune disease models, including experimental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis, as well as models of ocular inflammation ([1][1]–[4][2]). However, the